In Myriad, Did Supreme Court Confuse Its Own Precedent?
On June 13, 2013, the United States Supreme Court issued its long-awaited decision in Association for Molecular Pathology v. Myriad Genetics Inc., and held that isolated genes are not patent eligible...To view the full article, register now.
Already a subscriber? Click here to view full article